JESSICA HELMS: Open Payments
NPI 1023593308 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 16 payments from 10 companies in 2025. Trend: 2023 $217 · 2024 $500 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $225 |
| ABBVIE INC. | 5 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $95 |
| Janssen Biotech, Inc. | 1 | $40 |
| Ipsen Biopharmaceuticals, Inc | 1 | $31 |
| RedHill Biopharma Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $17 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, IQIRVO, Talicia, TRULANCE, EOHILIA.
Industry payments across TX — which companies pay providers there.
